tiprankstipranks
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
HRMY
Harmony Biosciences Holdings
RESEARCH TOOLSreports

Harmony Biosciences Holdings (HRMY) Income Statement

432 Followers

Harmony Biosciences Holdings Income Statement

Last quarter (Q4 2025), Harmony Biosciences Holdings's total revenue was $243.78M, an increase of 21.12% from the same quarter last year. In Q4, Harmony Biosciences Holdings's net income was $22.49M. See Harmony Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 868.45M$ 714.73M$ 582.02M$ 437.86M$ 305.44M
Gross Profit
$ 670.11M$ 557.92M$ 460.79M$ 354.37M$ 249.92M
Operating Expenses
$ 461.64M$ 367.09M$ 268.76M$ 234.19M$ 162.39M
Depreciation and Amortization
$ 25.34M$ 24.11M$ 24.36M$ 23.39M$ 18.84M
EBITDA
$ 255.05M$ 233.41M$ 221.51M$ 146.87M$ 80.46M
Operating Income
$ 208.47M$ 190.83M$ 192.03M$ 120.19M$ 87.53M
Other Income/Expenses
$ 6.59M$ 978.00K$ -18.63M$ -15.50M$ -50.10M
Pretax Income
$ 215.06M$ 191.80M$ 173.40M$ 104.69M$ 37.43M
Net Income
$ 158.69M$ 145.49M$ 128.85M$ 181.47M$ 34.60M
Per Share Metrics
Basic EPS
$ 2.76$ 2.56$ 2.17$ 3.07$ 0.60
Diluted EPS
$ 2.71$ 2.51$ 2.13$ 2.97$ 0.58
Weighted Average Shares Outstanding
 57.49M 56.88M 59.47M 59.17M 57.53M
Weighted Average Shares Outstanding (Diluted)
 58.54M 57.87M 60.37M 61.10M 59.21M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History